U.K. National Health Service Has New Drug Pricing Deal
An article in The Economist discusses the United Kingdom’s new drug pricing deal. As we know, all other developed nations negotiate and set prices globally, as Great Britain does. The Inflation Reduction Act’s Medicare drug price negotiation will slowly bring some of what other developed nations have. In fact, we have some in force now.
Key points from the article:
- The U.K. has among the lowest drug prices in the world because of its buying power. Imagine the buying power of America?
- The U.K. looks at the cost-effectiveness of new medicines to set prices.
- It also has inflationary caps of 2% per year, which will increase to 4% in the new deal. Anything over this is returned in a rebate. Some drugs are exempt to encourage innovation.
Still, the U.K. says it is getting hurt by high-cost cancer and other drugs.
The U.K. and other systems work and should be fully in place in America.
(Article may require a subscription.)
#drugpricing #medicare #partd #uk #nhs